Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants.

Aging is associated with appearance of white matter hyperintensities (WMH) on MRI scans. Vascular risk and inflammation, which increase with age, may contribute to white matter deterioration and proliferation of WMH. We investigated whether circulating biomarkers and genetic variants associated with elevated vascular risk and inflammation are associated with WMH volume in healthy adults (144 volunteers, 44-77 years of age). We examined association of WMH volume with age, sex, hypertension, circulating levels of total plasma homocysteine (tHcy), cholesterol (low-density lipoprotein), and C-reactive protein (CRP), and four polymorphisms related to vascular risk and inflammation: Apolipoprotein ε (ApoE ε2,3,4), Angiotensin-Converting Enzyme insertion/deletion (ACE I/D), methylenetetrahydrofolate reductase (MTHFR) C677T, C-reactive protein (CRP)-286C>A>T, and interleukin-1β (IL-1β) C-511T. We found that larger WMH volume was associated with advanced age, hypertension, and elevated levels of homocysteine and CRP but not with low-density lipoprotein levels. Homozygotes for IL-1β-511T allele and carriers of CRP-286T allele that are associated with increased inflammatory response had larger WMH than the other allelic combinations. Carriers of the APOE ε2 allele had larger frontal WMH than ε3 homozygotes and ε4 carriers did. Thus, in healthy adults, who are free of neurological and vascular disease, genetic variants that promote inflammation and elevated levels of vascular risk biomarkers can contribute to brain abnormalities. This article is part of a Special Issue entitled: Imaging Brain Aging and Neurodegenerative disease.

[1]  A D Roses,et al.  Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences , 1996, Annals of the New York Academy of Sciences.

[2]  T. Schmitz,et al.  Cytokines and Myelination in the Central Nervous System , 2008, TheScientificWorldJournal.

[3]  W. Jagust,et al.  C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype , 2008, Neurobiology of Aging.

[4]  Faith M. Gunning-Dixon,et al.  Aging of cerebral white matter: a review of MRI findings , 2009, International journal of geriatric psychiatry.

[5]  H Lechner,et al.  White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.

[6]  J. Wade,et al.  Vascular risk factors and leuko-araiosis. , 1987, Archives of neurology.

[7]  J. Grassi,et al.  Secretion of interleukin‐1β by astrocytes mediates endothelin‐1 and tumour necrosis factor‐α effects on human brain microvascular endothelial cell permeability , 2003 .

[8]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[9]  F. Fazekas,et al.  Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.

[10]  P. Sachdev,et al.  Sex differences in the causes and consequences of white matter hyperintensities , 2009, Neurobiology of Aging.

[11]  Carolyn Katrinchak,et al.  Clinical implications of C‐reactive protein as a predictor of vascular risk , 2007, Journal of the American Academy of Nurse Practitioners.

[12]  Antonella Plaia,et al.  Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis , 2008, Brain Research Reviews.

[13]  M. Goto Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? , 2008, Bioscience trends.

[14]  C. DeCarli,et al.  Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis , 2009, Stroke.

[15]  N. Prins,et al.  Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  S. Brod Unregulated inflammation shortens human functional longevity , 2000, Inflammation Research.

[17]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[18]  Bernhard T. Baune,et al.  Association Between Cytokines and Cerebral MRI Changes in the Aging Brain , 2009, Journal of geriatric psychiatry and neurology.

[19]  Y. Itoyama,et al.  Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. , 1995, Stroke.

[20]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[21]  André G. Uitterlinden,et al.  Genetic variation in homocysteine metabolism, cognition, and white matter lesions , 2010, Neurobiology of Aging.

[22]  N. Rothwell,et al.  Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Green,et al.  A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[25]  M. Orellana,et al.  Homocysteine and Essential Hypertension , 2003, Journal of clinical pharmacology.

[26]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[27]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[28]  P. Scheltens,et al.  Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old , 2010, Neurology.

[29]  Irving Kushner,et al.  C-reactive Protein* , 2004, Journal of Biological Chemistry.

[30]  P. Lazzerini,et al.  Hyperhomocysteinemia, inflammation and autoimmunity. , 2007, Autoimmunity reviews.

[31]  C. McCollum,et al.  Deletion/Insertion Polymorphism of the Angiotensin‐Converting Enzyme Gene and White Matter Hyperintensities in Dementia: A Pilot Study , 2006, Journal of the American Geriatrics Society.

[32]  Ulman Lindenberger,et al.  White matter deterioration in 15 months: latent growth curve models in healthy adults , 2012, Neurobiology of Aging.

[33]  C. Sudlow,et al.  Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.

[34]  Sanja Stankovic,et al.  Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors , 2010, Critical reviews in clinical laboratory sciences.

[35]  Faith M. Gunning-Dixon,et al.  Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study , 2003, Neuropsychologia.

[36]  H. Aizenstein,et al.  Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure , 2011, Journal of Human Hypertension.

[37]  G. Hansson Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[38]  Wang Min,et al.  Leuko araiosis , 2006 .

[39]  S. Marenco,et al.  Regional Cerebral Blood Flow in Chronic Hypertension: A Correlative Study , 1993, Stroke.

[40]  Nicolas Cherbuin,et al.  Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.

[41]  Zhijun Zhang,et al.  The D-allele of ACE insertion/deletion polymorphism is associated with regional white matter volume changes and cognitive impairment in remitted geriatric depression , 2010, Neuroscience Letters.

[42]  Michael H Lev,et al.  Regional Ischemic Vulnerability of the Brain to Hypoperfusion: The Need for Location Specific Computed Tomography Perfusion Thresholds in Acute Stroke Patients , 2011, Stroke.

[43]  Cheryl L. Dahle,et al.  Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.

[44]  L. Radloff The CES-D Scale , 1977 .

[45]  J. Hall,et al.  The renin-angiotensin system: renal actions and blood pressure regulation. , 1991, Comprehensive therapy.

[46]  J. Felblinger,et al.  Association Study of Gene Polymorphisms Involved in Vascular Alterations in Elderly Hypertensives with Subjective Memory Complaints , 2010, Dementia and Geriatric Cognitive Disorders.

[47]  J. H. Steiger Tests for comparing elements of a correlation matrix. , 1980 .

[48]  L. Fañanás,et al.  Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin‐1 beta gene (2q13) , 2008, Genes, brain, and behavior.

[49]  A. Pfefferbaum,et al.  Selective age-related degradation of anterior callosal fiber bundles quantified in vivo with fiber tracking. , 2006, Cerebral cortex.

[50]  A. de la Sierra,et al.  Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension , 2002, Hypertension.

[51]  H. Markus Genes, endothelial function and cerebral small vessel disease in man , 2008, Experimental physiology.

[52]  Karen M Rodrigue,et al.  Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. , 2003, Behavioral neuroscience.

[53]  Yaakov Stern,et al.  Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging , 2009, Psychiatry Research: Neuroimaging.

[54]  Jing He,et al.  Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. , 2010, Archives of neurology.

[55]  V. Thijs,et al.  Association of Apolipoprotein E ϵ2 With White Matter Disease but Not With Microbleeds , 2007 .

[56]  S. Black,et al.  Periventricular and subcortical hyperintensities on magnetic resonance imaging. 'Rims, caps, and unidentified bright objects'. , 1988, Archives of neurology.

[57]  P. Guarino,et al.  Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  R. C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[59]  Frederik Barkhof,et al.  Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study , 2008, Stroke.

[60]  Manuel Desco,et al.  Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene , 2005, NeuroImage.

[61]  T. Kemper,et al.  Neuroanatomical and neuropathological changes during aging and dementia. , 1994 .

[62]  A. Song,et al.  Cerebral White Matter Integrity and Cognitive Aging: Contributions from Diffusion Tensor Imaging , 2009, Neuropsychology Review.

[63]  M. Hurme,et al.  IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .

[64]  J. Kril,et al.  Neuropathologic correlates of white matter hyperintensities , 2008, Neurology.

[65]  B. Rossier,et al.  Physiological and pathophysiological role of the epithelial sodium channel in the control of blood pressure. , 1996, Kidney & blood pressure research.

[66]  Karen M Rodrigue,et al.  Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. , 2007, Neuropsychology.

[67]  M. Fornage,et al.  Genomewide association studies of stroke. , 2009, The New England journal of medicine.

[68]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[69]  Mark D'Esposito,et al.  Imaging the aging brain , 2009 .

[70]  Ihab Hajjar,et al.  Hypertension and Cerebral Vasoreactivity: A Continuous Arterial Spin Labeling Magnetic Resonance Imaging Study , 2010, Hypertension.

[71]  M. Province,et al.  Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate Response , 2008, Diabetes Care.

[72]  A. Peters The effects of normal aging on myelin and nerve fibers: A review , 2002, Journal of neurocytology.

[73]  J. Gabrieli,et al.  Insights into the ageing mind: a view from cognitive neuroscience , 2004, Nature Reviews Neuroscience.

[74]  A. Hingorani,et al.  Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. , 2004, Archives of neurology.

[75]  Silvia Kochen,et al.  Association study between interleukin 1β gene and epileptic disorders: a HuGe review and meta-analysis , 2008, Genetics in Medicine.

[76]  G. Bartzokis,et al.  In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia , 2009, Schizophrenia Research.

[77]  R. P. Stroemer,et al.  Cortical Protection by Localized Striatal Injection of IL-1ra Following Cerebral Ischemia in the Rat , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  D. Harvey,et al.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.

[79]  A Hofman,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[80]  Jennifer G. Robinson,et al.  Relationship of Hypertension, Blood Pressure, and Blood Pressure Control With White Matter Abnormalities in the Women’s Health Initiative Memory Study (WHIMS)—MRI Trial , 2010, Journal of clinical hypertension.

[81]  D. Head,et al.  Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.

[82]  S. Resnick,et al.  The Impact of Magnetic Resonance Imaging-Detected White Matter Hyperintensities on Longitudinal Changes in Regional Cerebral Blood Flow , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  L. Pantoni,et al.  Cognitive Impairment and Cellular/Vascular Changes in the Cerebral White Matter a , 1997, Annals of the New York Academy of Sciences.

[84]  Caleb E. Finch,et al.  Evolution of the human lifespan and diseases of aging: Roles of infection, inflammation, and nutrition , 2009, Proceedings of the National Academy of Sciences.

[85]  G. Wilcock,et al.  Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.

[86]  O B Paulson,et al.  Cerebral blood flow in untreated and treated hypertension. , 1995, The Netherlands journal of medicine.

[87]  Klaus Berger,et al.  CRP Gene Haplotypes, Serum CRP, and Cerebral Small-Vessel Disease: The Rotterdam Scan Study and the MEMO Study , 2007, Stroke.

[88]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[89]  E Rostrup,et al.  Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities , 2002, Stroke.

[90]  A. Kondacs,et al.  Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis , 2004, Acta neurologica Scandinavica.

[91]  Peter Kochunov,et al.  Whole Brain and Regional Hyperintense White Matter Volume and Blood Pressure: Overlap of Genetic Loci Produced by Bivariate, Whole-Genome Linkage Analyses , 2010, Stroke.

[92]  W. Brown,et al.  Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.

[93]  F. Cambien The angiotensin‐converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction , 1994, Clinical genetics.

[94]  N. Rothwell Cytokines ‐ killers in the brain? , 1999 .

[95]  D. Tate,et al.  Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. , 2003, Neuropsychology.

[96]  Bruce M Psaty,et al.  Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study , 2008, Stroke.

[97]  R. Heimburger,et al.  Impaired cerebral functions in essential hypertension. , 1951, The American journal of psychiatry.

[98]  Janice E. Knoefel,et al.  Clinical neurology of aging , 1985 .

[99]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[100]  A Hofman,et al.  C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.

[101]  B. Israelsson,et al.  Plasma homocysteine and methionine tolerance in early-onset vascular disease. , 1989, Haemostasis.

[102]  Thomas E. Nichols,et al.  Lesion probability maps of white matter hyperintensities in elderly individuals , 2006, Journal of Neurology.

[103]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[104]  A. Słowik,et al.  Interleukin 1 Beta Polymorphism (–511) and Risk of Stroke due to Small Vessel Disease , 2005, Cerebrovascular Diseases.

[105]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.